Cargando…
Correction: Discovery of a FLT3 inhibitor LDD1937 as an anti-leukemic agent for acute myeloid leukemia
Autores principales: | Lee, Hyo Jeong, Lee, Jungeun, Jeong, Pyeonghwa, Choi, Jungil, Baek, Juhwa, Ahn, Su lin, Moon, Yeongyu, Heo, Jeong Doo, Choi, Young Hee, Chin, Young-Won, Kim, Yong-Chul, Han, Sun-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929457/ https://www.ncbi.nlm.nih.gov/pubmed/29733074 http://dx.doi.org/10.18632/oncotarget.25141 |
Ejemplares similares
-
Discovery of a FLT3 inhibitor LDD1937 as an anti-leukemic agent for acute myeloid leukemia
por: Lee, Hyo Jeong, et al.
Publicado: (2017) -
Characterization of LDD-2633 as a Novel RET Kinase Inhibitor with Anti-Tumor Effects in Thyroid Cancer
por: Lee, Hyo Jeong, et al.
Publicado: (2021) -
Characterization of KRC-108 as a TrkA Kinase Inhibitor with Anti-Tumor Effects
por: Lee, Hyo Jeong, et al.
Publicado: (2022) -
Chemical characterization and biological activity data for a novel indirubin derivative, LDD-1819
por: Kim, Woong-Hee, et al.
Publicado: (2019) -
Characterization of the Indirubin Derivative LDD970 as a Small Molecule Aurora Kinase A Inhibitor in Human Colorectal Cancer Cells
por: Ndolo, Karyn Muzinga, et al.
Publicado: (2017)